Bio-Works confirms order from new production customer for oligonucleotide manufacturing
Today, Bio-Works Technologies AB has confirmed an order worth 2.3 MSEK for WorkBeads chromatography resins to be used in the manufacture of oligonucleotides. The customer is an American contract manufacturer who offers cGMP manufacturing to other pharmaceutical companies. They are part of a larger American conglomerate with 17 000 employees globally. Delivery is planned early in the third quarter of this year.”For over a year, we have said that there are opportunities for Bio-Works to expand on our success with peptides in the oligo market. This order confirms that our theory is correct,”